Channel-forming activity of syringomycin (cas 11140-67-3) E in two mercury-supported biomimetic membranes
-
Add time:07/22/2019 Source:sciencedirect.com
The lipodepsipeptide syringomycin (cas 11140-67-3) E (SR-E) interacts with two mercury-supported biomimetic membranes, which consist of a self-assembled phospholipid monolayer (SAM) and of a tethered bilayer lipid membrane (tBLM) separated from the mercury surface by a hydrophilic tetraethyleneoxy (TEO) spacer that acts as an ionic reservoir. SR-E interacts more rapidly and effectively with a SAM of dioleoylphosphatidylserine (DOPS) than with one of dioleoylphosphatidylcholine (DOPC). The proximal lipid monolayer of the tBLM has no polar head region, being linked to the TEO spacer via an ether bond, while the distal monolayer consists of either a DOPC or a DOPS leaflet. The ion flow into or out of the spacer through the lipid bilayer moiety of the tBLM was monitored by potential step chronocoulometry and cyclic voltammetry. With the distal monolayer bathed by aqueous 0.1 M KCl and 0.8 μM SR-E, an ion flow in two stages was monitored with DOPC at pH 3 and 5.4 and with DOPS at pH 3, while a single stage was observed with DOPS at pH 5.4. This behavior was compared with that already described at conventional bilayer lipid membranes. The sigmoidal shape of the chronocoulometric charge transients points to an aggregation of SR-E monomers forming an ion channel via a mechanism of nucleation and growth. The ion flow is mainly determined by potassium ions, and is inhibited by calcium ions. The contribution to the transmembrane potential from the distal leaflet depends more on the nature of the lipid than that of the ion channel.
We also recommend Trading Suppliers and Manufacturers of syringomycin (cas 11140-67-3). Pls Click Website Link as below: cas 11140-67-3 suppliers
Prev:Structure of the lipodepsipeptide syringomycin (cas 11140-67-3) E in phospholipids and sodium dodecylsulphate micelle studied by circular dichroism, NMR spectroscopy and molecular dynamics
Next:Role of ergosterol in growth inhibition of Saccharomyces cerevisiae by syringomycin (cas 11140-67-3) E) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Requirement of sphingolipid α-hydroxylation for fungicidal action of syringomycin (cas 11140-67-3) E07/27/2019
- The structure of syringomycin (cas 11140-67-3)s A1, E and G07/26/2019
- The effect of sterols on the sensitivity of membranes to the channel-forming antifungal antibiotic, syringomycin (cas 11140-67-3) E07/25/2019
- Mutational analysis and homology modelling of SyrC, the aminoacyltransferase in the biosynthesis of syringomycin (cas 11140-67-3)07/24/2019
- Role of ergosterol in growth inhibition of Saccharomyces cerevisiae by syringomycin (cas 11140-67-3) E07/23/2019
- Structure of the lipodepsipeptide syringomycin (cas 11140-67-3) E in phospholipids and sodium dodecylsulphate micelle studied by circular dichroism, NMR spectroscopy and molecular dynamics07/20/2019
- Lipid-mediated regulation of pore-forming activity of syringomycin (cas 11140-67-3) E by thyroid hormones and xanthene dyes07/21/2019